Neurophet
Healthcare Software · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Samwon Tower 124 Teheran-ro Gangnam-gu 1...Website
www.neurophet.comRevenue
$9.7 MillionIndustry
About Neurophet
Neurophet Org Chart
Is Neurophet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Neurophet is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Neurophet
Website visits: Recent activity has been detected on your website
Neurophet, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neurophet recently announced quarterly report
Product Launch: Get notified when Neurophet launches new products
Click to see if Neurophet had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Neurophet has new funding data
Check if Neurophet has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Neurophet
Find 2 more new buyers
Company Profile Activity
Activity Insights
Neurophet is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Neurophet is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Neurophet.
Neurophet Tech Stack
A closer look at the technologies used by Neurophet
Most Recent Scoops
Neurophet News & Media
Neurophet Supplies 'Neurophet AQUA' to Raffles Medical in Singapore
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical reference SEOUL, South Korea, July 2, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for...Neurophet Launches Joint Study with VHIR on 'Neurophet AQUA MS', Accelerating AI Algorithm Validation
Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial dataset Leveraging large-scale, multi-center brain MRI datasets to detect key lesion biomarkers SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon...Neurophet Appoints Globally Renowned Imaging AI Expert Dr. Lawrence N. Tanenbaum as Scientific Advisor
Former Vice President and Chief Technology Officer of RadNet, one of the largest outpatient imaging providers in the United States Appointment expected to strengthen clinical validation, global expansion, and competitiveness in neuroimaging AI SEOUL, South Korea, May 21, 2026 /PRNewswire/...Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer's Disease Therapies
Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions Collaboration expected to leverage Neurophet AQUA, Neurophet SCALE PET and Neurophet AQUA AD Plus SEOUL, South Korea, March 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs...
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurophet
Founded in 2016, 뉴로핏 is a specialized company that develops brain imaging analysis solutions and therapeutic medical devices based on artificial intelligence (AI) technology. Their focus encompasses the entire cycle of diagnosis, treatment guidance, and therapy.... Read More
